ArticleFrontiers in immunology2024

Case report: Abrocitinib: a potential therapeutic option for lichen amyloidosis associated with atopic dermatitis.

Yizhen Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.